ClinVar Miner

Submissions for variant NM_001999.4(FBN2):c.3209T>A (p.Phe1070Tyr)

gnomAD frequency: 0.00001  dbSNP: rs139118782
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000196552 SCV000250184 uncertain significance not provided 2015-02-18 criteria provided, single submitter clinical testing p.Phe1070Tyr (TTT>TAT): c.3209 T>A in exon 24 of the FBN2 gene (NM_001999.3) Mutations in the FBN2 gene have been reported in 27-75% of patients with autosomal dominant congenital contracturalarachnodactyly, which is associated with a risk of aortic root dilatation (Godfrey M et al., 2012). The F1070Y variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The F1070Y variant was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The F1070Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. No missense mutations in nearby residues have been reported, indicating this region of the protein may tolerate change. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. This variant was found in TAADV2-1
Mayo Clinic Laboratories, Mayo Clinic RCV000196552 SCV002542134 uncertain significance not provided 2021-07-08 criteria provided, single submitter clinical testing
Invitae RCV002515357 SCV003446099 benign Congenital contractural arachnodactyly 2022-09-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.